Published in J Clin Invest on July 01, 2007
Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med (2010) 3.10
RAGE signaling sustains inflammation and promotes tumor development. J Exp Med (2008) 2.51
Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood (2008) 2.26
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol (2008) 2.08
Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity (2009) 1.95
Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J Clin Invest (2012) 1.73
The immune system and developmental programming of brain and behavior. Front Neuroendocrinol (2012) 1.36
Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol (2008) 1.25
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut (2012) 1.22
Immune regulation by atypical chemokine receptors. Nat Rev Immunol (2013) 1.17
The role of chemokines and their receptors in angiogenesis. Cell Mol Life Sci (2011) 1.15
Atypical chemokine receptors. Exp Cell Res (2011) 0.96
New nomenclature for atypical chemokine receptors. Nat Immunol (2014) 0.94
D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood (2011) 0.93
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol (2012) 0.90
The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol (2009) 0.89
Myeloid cells and lymphangiogenesis. Cold Spring Harb Perspect Med (2012) 0.88
CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res (2011) 0.88
Loss of Grainy head-like 1 is associated with disruption of the epidermal barrier and squamous cell carcinoma of the skin. PLoS One (2014) 0.85
DARC and D6: silent partners in chemokine regulation? Immunol Cell Biol (2010) 0.84
Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence. J Biol Chem (2009) 0.83
Cytokines in chronic rheumatic diseases: is everything lack of homeostatic balance? Arthritis Res Ther (2009) 0.82
p53, chemokines, and squamous cell carcinoma. J Clin Invest (2007) 0.81
High expression of CRAM correlates with poor prognosis in patients with cervical carcinoma. Int J Clin Exp Pathol (2014) 0.80
Cell-autonomous regulation of neutrophil migration by the D6 chemokine decoy receptor. J Immunol (2013) 0.80
Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice. J Biol Chem (2013) 0.80
Lymphatic Regulation of Cellular Trafficking. J Clin Cell Immunol (2014) 0.78
The atypical chemokine receptor ACKR2 suppresses Th17 responses to protein autoantigens. Immunol Cell Biol (2014) 0.78
Epidermal α6β4 integrin stimulates the influx of immunosuppressive cells during skin tumor promotion. J Dermatol Sci (2012) 0.77
Atypical Chemokine Receptors and Their Roles in the Resolution of the Inflammatory Response. Front Immunol (2016) 0.77
Atypical chemokine receptor D6 inhibits human non-small cell lung cancer growth by sequestration of chemokines. Oncol Lett (2013) 0.77
Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective. Biomed Rep (2013) 0.77
The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding. J Biol Chem (2014) 0.77
Atypical chemokine receptor 2: a brake against Kaposi's sarcoma aggressiveness. Oncoimmunology (2015) 0.76
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2. J Invest Dermatol (2016) 0.76
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation. Cytokine (2016) 0.76
Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland. Development (2016) 0.75
ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology. Front Immunol (2017) 0.75
Potential Role of Chemokines in Fracture Repair. Front Endocrinol (Lausanne) (2017) 0.75
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell (2004) 15.82
NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature (2004) 15.14
Paradoxical roles of the immune system during cancer development. Nat Rev Cancer (2006) 10.57
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med (2001) 9.99
The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81
Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell (2005) 9.06
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell (2000) 8.00
The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin. Proc Natl Acad Sci U S A (1999) 7.67
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev (1999) 6.10
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
Regulation of cutaneous malignancy by gammadelta T cells. Science (2001) 5.83
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell (2005) 5.79
Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat Med (1999) 4.41
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell (2004) 4.23
CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat Med (2002) 4.02
Integrated signalling pathways for mast-cell activation. Nat Rev Immunol (2006) 3.93
CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med (2001) 3.51
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet (2004) 3.38
The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol (2005) 2.98
Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol (2006) 2.92
Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors. Cell (1993) 2.62
CCL2 (monocyte chemoattractant protein-1) and cancer. Semin Cancer Biol (2004) 2.11
Focus on head and neck cancer. Cancer Cell (2004) 2.11
Resident skin-specific gammadelta T cells provide local, nonredundant regulation of cutaneous inflammation. J Exp Med (2002) 2.08
CXC chemokines in angiogenesis. Cytokine Growth Factor Rev (2005) 2.00
Immune enhancement of skin carcinogenesis by CD4+ T cells. J Exp Med (2003) 1.84
The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol (2001) 1.80
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int J Cancer (1988) 1.57
Immune activation and chronic inflammation as the cause of malignancy in oral lichen planus: is there any evidence ? Oral Oncol (2004) 1.53
Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol (2003) 1.52
The distinct contributions of murine T cell receptor (TCR)gammadelta+ and TCRalphabeta+ T cells to different stages of chemically induced skin cancer. J Exp Med (2003) 1.51
Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6. J Biol Chem (1997) 1.46
Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol (2004) 1.43
beta-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem (2004) 1.39
Increased inflammation in mice deficient for the chemokine decoy receptor D6. Eur J Immunol (2005) 1.37
The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J (2006) 1.33
Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis (2004) 1.31
Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression. Genes Dev (2004) 1.31
Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A (2007) 1.29
Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor. J Immunol (2004) 1.19
Chemokines on the move: control by the chemokine "interceptors" Duffy blood group antigen and D6. Semin Immunol (2003) 1.18
The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med (2006) 1.15
Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression. Int J Cancer (2006) 1.10
Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions. J Clin Invest (2005) 1.06
Divergent routes to oral cancer. Cancer Res (2006) 0.99
PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways. Cancer Res (2006) 0.98
Human mast cell chemokines receptors: implications for mast cell tissue localization in asthma. Clin Exp Allergy (2005) 0.79
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A (2011) 3.37
The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol (2005) 2.98
Should we be surprised at the paucity of response to EGFR inhibitors? Lancet Oncol (2009) 2.21
International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev (2013) 2.11
The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol (2008) 2.08
Peritrabecular clefting in fibrous dysplasia of the jaws: an important histopathologic feature for differentiating fibrous dysplasia from central ossifying fibroma. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 1.97
The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell (2004) 1.60
Sentinel node biopsy in head and neck squamous cell cancer: 5-year follow-up of a European multicenter trial. Ann Surg Oncol (2010) 1.36
Ticks produce highly selective chemokine binding proteins with antiinflammatory activity. J Exp Med (2008) 1.34
Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol (2008) 1.29
Transcriptional analysis of quiescent and proliferating CD34+ human hemopoietic cells from normal and chronic myeloid leukemia sources. Stem Cells (2007) 1.24
Immune regulation by atypical chemokine receptors. Nat Rev Immunol (2013) 1.17
The chemokine receptor D6 has opposing effects on allergic inflammation and airway reactivity. Am J Respir Crit Care Med (2006) 1.15
A murine specific expansion of the Rhox cluster involved in embryonic stem cell biology is under natural selection. BMC Genomics (2006) 1.12
CD56 (NCAM) expression in ameloblastomas and other odontogenic lesions. Histopathology (2010) 1.10
Purification and biochemical characterization of the D6 chemokine receptor. Biochem J (2004) 1.07
Astrocytes modulate the chemokine network in a pathogen-specific manner. Biochem Biophys Res Commun (2010) 1.06
Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J Clin Oncol (2010) 1.04
Cutting edge: the silent chemokine receptor D6 is required for generating T cell responses that mediate experimental autoimmune encephalomyelitis. J Immunol (2006) 1.04
MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One (2013) 1.04
IL-33 activates B1 cells and exacerbates contact sensitivity. J Immunol (2011) 1.01
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.99
Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem (2008) 0.99
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol (2008) 0.97
A retrospective analysis of histological prognostic factors for the development of lymph node metastases from auricular squamous cell carcinoma. Histopathology (2010) 0.96
An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann Rheum Dis (2011) 0.95
A TLR2 ligand suppresses inflammation by modulation of chemokine receptors and redirection of leukocyte migration. Blood (2009) 0.95
Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex. Eur J Immunol (2009) 0.94
D6 facilitates cellular migration and fluid flow to lymph nodes by suppressing lymphatic congestion. Blood (2011) 0.93
Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol (2010) 0.92
Peripheral inflammation is associated with remote global gene expression changes in the brain. J Neuroinflammation (2014) 0.91
Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am J Pathol (2012) 0.90
Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha. Blood (2002) 0.90
The chemokine ESkine/CCL27 displays novel modes of intracrine and paracrine function. J Immunol (2002) 0.90
An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood (2013) 0.90
The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses. Blood (2010) 0.90
D6: the 'crowd controller' at the immune gateway. Trends Immunol (2012) 0.89
Structure-function dissection of D6, an atypical scavenger receptor. Methods Enzymol (2009) 0.89
Endothelin-1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal-epithelial interactions. Int J Cancer (2011) 0.89
Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD. Respir Res (2013) 0.86
High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. Histopathology (2011) 0.85
Influence of Slc11a1 (formerly Nramp1) on DSS-induced colitis in mice. J Leukoc Biol (2008) 0.84
Cloning and characterization of Ehox, a novel homeobox gene essential for embryonic stem cell differentiation. J Biol Chem (2002) 0.84
IgG4-related sclerosing disease clinically mimicking oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol (2012) 0.83
Microarray analyses demonstrate the involvement of type I interferons in psoriasiform pathology development in D6-deficient mice. J Biol Chem (2013) 0.80
Dimeric integrin alpha5beta1 ligands confer morphological and differentiation responses to murine embryonic stem cells. Biochem Biophys Res Commun (2009) 0.80
Acute inflammatory response to cobalt chromium orthopaedic wear debris in a rodent air-pouch model. J R Soc Interface (2012) 0.80
CCL27/PESKY: a novel paradigm for chemokine function. Expert Opin Biol Ther (2003) 0.80
Post-weaning diet determines metabolic risk in mice exposed to overnutrition in early life. Reprod Biol Endocrinol (2014) 0.79
Evaluating the use of optical coherence tomography for the detection of epithelial cancers in vitro. J Biomed Opt (2011) 0.79
A310 helical turn is essential for the proliferation-inhibiting properties of macrophage inflammatory protein-1 alpha (CCL3). Blood (2005) 0.79
Localized idiopathic internal resorption in the primary dentition. J Clin Pediatr Dent (2010) 0.78
Mandibular reconstruction in the rabbit using beta-tricalcium phosphate (β-TCP) scaffolding and recombinant bone morphogenetic protein 7 (rhBMP-7) - histological, radiographic and mechanical evaluations. J Craniomaxillofac Surg (2012) 0.78
The N-terminal region of the atypical chemokine receptor ACKR2 is a key determinant of ligand binding. J Biol Chem (2014) 0.77
Oestrogen receptor β in adenoid cystic carcinoma of salivary glands. Histopathology (2012) 0.77
Flow cytometry applications for the analysis of chemokine receptor expression and function. Cytometry A (2014) 0.76
Is next-generation sequencing an important tool in HPV subtype diagnosis? Expert Rev Mol Diagn (2012) 0.76
Peritrabecular clefting in fibrous dysplasia of the jaws: how soon is now? Oral Surg Oral Med Oral Pathol Oral Radiol (2013) 0.75
Corrigendum: CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses. Sci Rep (2017) 0.75
Crystal storing histiocytosis of the tongue as the initial presentation of multiple myeloma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2011) 0.75